Stay updated on Crisaborole Ointment for Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Crisaborole Ointment for Atopic Dermatitis Clinical Trial page.

Latest updates to the Crisaborole Ointment for Atopic Dermatitis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision: v3.3.4 was added, replacing the previous revision v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedExpanded study locations to include new site listings across the US (CA, CO, FL, IN, LA, MI, NE, OH, OK, TN, TX, UT, VA, WA), Canada (Ontario, Saskatchewan), Australia (New South Wales), and multiple China regions (Beijing, Fujian, Guangdong, Hubei, Jiangxi, Shanghai, Tianjin, Yunnan, Zhejiang) with revision tag v3.3.3; prior location entries were removed.SummaryDifference2%

- Check52 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

- Check59 days agoChange DetectedAdded a PubMed Publications note clarifying that publications are automatically filled from PubMed and may not pertain to the study, and updated the revision to v3.3.1, replacing the previous PubMed listing language aligned with v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check67 days agoChange DetectedRemoved the government funding lapse notice from the page; the core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check81 days agoChange DetectedNo additions or deletions were detected; the page content appears unchanged.SummaryDifference0.3%

Stay in the know with updates to Crisaborole Ointment for Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crisaborole Ointment for Atopic Dermatitis Clinical Trial page.